Histology and cytology refers to the microscopic examination of tissues and cells for purposes of diagnosis. Histology entails the examination of tissue samples to study the microscopic structure and organization of cells and tissues. Whereas, cytology involves the microscopic examination of cells obtained from bodily secretions, tissues or fluids for diagnosis of cancer and other diseases. Common cytology tests include pap smear for cervical cancer screening and fine needle aspiration for breast, lung and thyroid cancer diagnosis. Histology and cytology plays a vital role in the diagnosis as well as determining the degree and severity of diseases. The global histology and cytology market is primarily driven by rising cases of cancer and growing availability of advanced diagnostic technologies. Histology and cytology aids in early detection of cancer so that timely treatment can be started thus minimizing treatment costs and improving patient outcomes. The growing demand for minimally invasive diagnostic procedures and automated devices for disease diagnosis is favouring the market growth.
The global histology and cytology Market is estimated to be valued at US$ 20882.22 Mn in 2023 and is expected to exhibit a CAGR of 13.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
Increased adoption of automated diagnostic systems is expected to drive the global histology and cytology market during the forecast period. Automated systems aid in processing large volumes of specimen effectively and efficiently with minimal errors. This reduces physician workload and turnaround time for test results. For instance, Hologic Inc. offers automated microscopy systems such as Panther Fusion for molecular diagnostics of cancers and infectious diseases directly from thinly prepared tissue samples. The high adoption of automated diagnostic devices is attributed to benefits such as maximizing workflow efficiency, minimizing laboratory expenses and improving overall quality of diagnosis.
Rising cancer cases as mentioned in the heading is another major factor favouring the histology and cytology market. Early diagnosis through screening helps to detect cancer at an early stage when treatment is more effective and cure rates are high. This minimizes cancer treatment costs in the long run. Thus, growing cancer burden worldwide is creating significant demand for histology and cytology tests for timely diagnosis and management of the disease.
Segment Analysis
The global histology and cytology market is dominated by consumables sub-segment. The consumables account for nearly 75% of the market share owing to increasing consumption of reagents, antibodies, probes, kits and others for staining, immunohistochemistry and in-situ hybridization applications. The dominance of consumables sub-segment is attributed to recurring purchase of these products as against instruments which have longer replacement cycle.
PEST Analysis
Political: Governments across the globe are promoting cancer screening programs which is positively impacting the market growth. Economic: Rising healthcare spending coupled with growing economy is fueling the market expansion. Social: Increasing cancer incidence along with growing awareness about early disease diagnosis is propelling the demand for histology and cytology diagnostic tests. Technological: Advancements in digital pathology and automation is augmenting the adoption of new devices and platforms.
Key Takeaways
The Global Histology And Cytology Market Growth is expected to witness high at a CAGR of 13% during the forecast period of 2023 to 2030. Regionally, North America is expected to dominate the market attributed to expanding base of diagnostic laboratories and cancer research activities. Key players operating in the histology and cytology market are Abbott, Hologic Inc., Becton, Dickinson and Company, Southwest Precision Instruments, LLC, F. Hoffmann-La Roche Ltd, Sysmex Corporation, Thermo Fisher Scientific Inc., Danaher, Life Technologies Corporation, Merck KGaA, Koninklijke Philips N.V., Perkin Elmer, and Trivitron Healthcare. Key players are focused on new product launches and collaboration activities to strengthen their market position.
Regional analysis related content comprises North America historically dominates the global histology and cytology market owing to aging population, increasing cancer burden and favorable reimbursement policies in the region. The Asia Pacific region is poised to witness fastest growth over the forecast period driven by growing healthcare spending, rapidly developing healthcare infrastructure and expansion of private diagnostic labs in emerging countries like India and China.
Key players related content comprisesKey players operating in the histology and cytology market are Abbott, Hologic Inc., Becton, Dickinson and Company. These players are focusing on new product launches and geographical expansion to garner higher market share.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
